-
RSV Vaccines May Increase Risk of Rare Neurological Condition -
CDC Officials Investigating Nervous System Disorder in New Vaccine Recipients
-
RSV Shown to Damage Nerve Cells and Trigger Inflammation
-
Children Have Higher Hospitalizations From RSV Than Omicron or Influenza
-
New Shot Effective in Preventing RSV Hospitalization in Infants: Study
-
Few Seniors Taking RSV Vaccines; Most Adults Decline New COVID-19 Shots: CDC Studies
-
RSV Vaccine Added to List of 2024 Childhood Immunizations, Mpox Recommended for At-Risk Young Adults
-
CDC Director Believes US May Have Hit Peak of RSV
-
Respiratory Illnesses on the Rise Across the US, CDC Warns
-
COVID-19 Is Less Frequent and Severe in Infants Than Other Respiratory Viruses, Study Finds
-
CDC Issues Alert on Shortage of Key Children’s Medication
-
RSV Treatment for Infants in Limited Supply: CDC
-
CDC Advisers Recommend Pfizer RSV Vaccine for Pregnant Women
-
COVID-19, RSV, and Flu May Place ‘Significant Strain’ on Health System: CDC
-
CDC Warns RSV Cases Are Rising Among Infants, Babies
-
FDA Approves Drug Aimed at Preventing Respiratory Disease in Babies and Toddlers
-
CDC Panel Divided on Recommending RSV Vaccine for All Older Adults
-
CDC Advisers Recommend Use of GSK, Pfizer RSV Vaccines for Adults Aged 65 and Over
-
FDA Panel Unanimously Endorses New RSV Antibody Drug for Infants
-
Parents Urged to Be on Winter Alert for RSV
-
FDA Approves Pfizer’s RSV Vaccine for Older Adults
-
FDA Advisers Back Maternal RSV Vaccine as Pfizer Says Safety Concerns Can Be Studied Post-Approval
-
After Decades of Setbacks, First-Ever RSV Vaccine Approved: A Closer Look
-
Pfizer Data Says RSV Vaccine 82 Percent Effective in Newborns When Given to Pregnant Mothers
-
FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
-
FDA Panel Endorses Pfizer’s RSV Vaccine for Older Adults
-
Why Is the World Witnessing an Unprecedented Breakout of Infections?
